Christopher Scotten
Podiatrist · Denver, CONPI 1316473408
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,815 of the $6,571 with a category attached, or 88.5%. Gemini Mountain Medical, LLC accounts for 89.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $3,667 and has fallen 93.9% since, to $224 in 2025.
Across 24 payments — averaging $273.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gemini Mountain Medical, LLC$6K
- Smith+Nephew$331
- Organogenesis Inc.$202
- Bioventus LLC$86
- DJO, LLC$34
- Mimedx Group, Inc.$30
- plus $31 from 2 others
What the payments were for
- Food & beverage$75712%
- Education$5,81588%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gemini Mountain Medical, LLC | 7 | $5,856 |
| Smith+Nephew | 5 | $331 |
| Organogenesis Inc. | 4 | $202 |
| Bioventus LLC | 4 | $86 |
| DJO, LLC | 1 | $34 |
| Mimedx Group, Inc. | 1 | $30 |
| Treace Medical Concepts, Inc. | 1 | $16 |
| Orthofix Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,571 in reported general payments places this provider in the 75th percentile of 70 podiatrist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 178 | $5,808 |
| Ketoconazole | 171 | $2,421 |
| Doxycycline Hyclate | 12 | $175 |
| Methylprednisolone | 12 | $88 |
| Gabapentin | 13 | $87 |
| Meloxicam | 18 | $18 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Denver
- Amber KavanaghDenver$20K
- Kenneth MorganDenver$20K
- Andrea BatraDenver$12K
- Varun ChopraDenver$10K
- Eric HillmannDenver$9K
- Kevin NguyenDenver$9K
- Oliver KnauerDenver$7K
- Olivia AlloreDenver$4K
- Angela TebaldiDenver$3K
- Eugene RosenthallDenver$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.